188 related articles for article (PubMed ID: 20594859)
21. Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2.
Lu L; Zhao TT; Liu TB; Sun WX; Xu C; Li DD; Zhu HL
Chem Pharm Bull (Tokyo); 2016 Nov; 64(11):1570-1575. PubMed ID: 27568484
[TBL] [Abstract][Full Text] [Related]
22. 3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.
Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Pottoo FH; Jha M
Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900262. PubMed ID: 32003485
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, Molecular Modeling and Antitumor Evaluation of Novel Indolyl-Pyrimidine Derivatives with EGFR Inhibitory Activity.
Ahmed NM; Youns MM; Soltan MK; Said AM
Molecules; 2021 Mar; 26(7):. PubMed ID: 33805918
[TBL] [Abstract][Full Text] [Related]
24. Metronidazole aryloxy, carboxy and azole derivatives: Synthesis, anti-tumor activity, QSAR, molecular docking and dynamics studies.
Faghih-Mirzaei E; Sabouri S; Zeidabadinejad L; AbdolahRamazani S; Abaszadeh M; Khodadadi A; Shamsadinipour M; Jafari M; Pirhadi S
Bioorg Med Chem; 2019 Jan; 27(2):305-314. PubMed ID: 30554970
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFR
Gaber AA; Bayoumi AH; El-Morsy AM; Sherbiny FF; Mehany ABM; Eissa IH
Bioorg Chem; 2018 Oct; 80():375-395. PubMed ID: 29986185
[TBL] [Abstract][Full Text] [Related]
26. New cinnamic acid-pregenolone hybrids as potential antiproliferative agents: Design, synthesis and biological evaluation.
Ge YX; Wang YH; Zhang J; Yu ZP; Mu X; Song JL; Wang YY; Yang F; Meng N; Jiang CS; Zhang H
Steroids; 2019 Dec; 152():108499. PubMed ID: 31536733
[TBL] [Abstract][Full Text] [Related]
27. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
El-Sayed NA; Nour MS; Salem MA; Arafa RK
Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
[TBL] [Abstract][Full Text] [Related]
28. A Multi-action Pt
Kostrhunova H; Zajac J; Markova L; Brabec V; Kasparkova J
Angew Chem Int Ed Engl; 2020 Nov; 59(47):21157-21162. PubMed ID: 32750194
[TBL] [Abstract][Full Text] [Related]
29. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
[TBL] [Abstract][Full Text] [Related]
30. Dual EGFR/HER2 inhibitors and apoptosis inducers: New benzo[g]quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers.
Ghorab MM; Alsaid MS; Soliman AM
Bioorg Chem; 2018 Oct; 80():611-620. PubMed ID: 30041137
[TBL] [Abstract][Full Text] [Related]
31. Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile.
Mghwary AE; Gedawy EM; Kamal AM; Abuel-Maaty SM
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):838-852. PubMed ID: 30919701
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis and Biological Evaluation of Benzohydrazide Derivatives Containing Dihydropyrazoles as Potential EGFR Kinase Inhibitors.
Wang HC; Yan XQ; Yan TL; Li HX; Wang ZC; Zhu HL
Molecules; 2016 Aug; 21(8):. PubMed ID: 27527130
[TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis and Anticancer Evaluation of Substituted Cinnamic Acid Bearing 2-Quinolone Hybrid Derivatives.
Abu Almaaty AH; Elgrahy NA; Fayad E; Abu Ali OA; Mahdy ARE; Barakat LAA; El Behery M
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443308
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents.
Yang XH; Xiang L; Li X; Zhao TT; Zhang H; Zhou WP; Wang XM; Gong HB; Zhu HL
Bioorg Med Chem; 2012 May; 20(9):2789-95. PubMed ID: 22503364
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents.
Hisham M; Youssif BGM; Osman EEA; Hayallah AM; Abdel-Aziz M
Eur J Med Chem; 2019 Aug; 176():117-128. PubMed ID: 31108261
[TBL] [Abstract][Full Text] [Related]
36. Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
Zayed MF; Ahmed S; Ihmaid S; Ahmed HEA; Rateb HS; Ibrahim SRM
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891789
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation and molecular modeling study of [1,2,4]-Triazolo[4,3-c]quinazolines: New class of EGFR-TK inhibitors.
Ewes WA; Elmorsy MA; El-Messery SM; Nasr MNA
Bioorg Med Chem; 2020 Apr; 28(7):115373. PubMed ID: 32085964
[TBL] [Abstract][Full Text] [Related]
38. Azole-hydrazone derivatives: Design, synthesis, in vitro biological evaluation, dual EGFR/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents.
Labib MB; Philoppes JN; Lamie PF; Ahmed ER
Bioorg Chem; 2018 Feb; 76():67-80. PubMed ID: 29153588
[TBL] [Abstract][Full Text] [Related]
39. Cinnamic acid derivatives induce cell cycle arrest in carcinoma cell lines.
Sova M; Žižak Ž; Stanković JA; Prijatelj M; Turk S; Juranić ZD; Mlinarič-Raščan I; Gobec S
Med Chem; 2013 Aug; 9(5):633-41. PubMed ID: 23140579
[TBL] [Abstract][Full Text] [Related]
40. Microwave-assisted Single Step Cinnamic Acid Derivatization and Evaluation for Cytotoxic Potential.
Mishra S; Singh S; Ali A; Gupta AC; Shanker K; Bawankule DU; Luqman S
Curr Pharm Biotechnol; 2020; 21(3):236-243. PubMed ID: 31613725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
